Gabapentin Capsule
Product Images NDC 71335-1496

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1496). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

An illustration showing the formula to calculate creatinine clearance (CLCr). The formula includes age in years, weight in kilograms, serum creatinine in mg/dL, and a multiplier of 0.85 for female patients.*

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Line graph illustrating the mean pain score over 8 weeks comparing placebo and Gabapentin at 3600 mg/day. The horizontal axis represents weeks from baseline through weeks 1 to 8, with an indicated 4-week dose titration period followed by a 4-week fixed dose period. The vertical axis shows the mean pain score ranging from 0 to 10. Gabapentin group scores steadily decrease over time, while placebo scores remain relatively constant.*

FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

A line graph showing mean pain scores over 7 weeks comparing placebo with Gabapentin at 1800 mg/day and 2400 mg/day. The x-axis represents weeks, including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin groups show a decline in pain scores over time compared to placebo.*

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) at dosages of 1800, 2400, and 3600 mg across two studies. The chart shows response rates with significant differences noted between treatment and placebo groups.*

FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

A chart illustrating the difference percentage on the y-axis versus daily dose in mg on the x-axis. It compares data from three studies labeled as Study a, Study b, and Study c at doses approximately 600 mg, 900 mg, 1200 mg, and 1800 mg, showing variations in difference percentages across these doses.*

FDA Label Image

Label (Lbl713351496)

Gabapentin Capsules, USP 400 mg label from Bryant Ranch Prepack. The label indicates the product contains 90 capsules and is for prescription use only. It includes storage instructions at 20° to 25° C, a caution about potential dizziness, and features the BRP Pharmaceuticals logo. NDC 71335-1496-01 is displayed along with a barcode.*

FDA Label Image

Label (Lbl7133514962)

Gabapentin 400 mg Capsule label by Bryant Ranch Prepack. The label indicates a comparison to Neurontin 400 mg Capsule by Alkem Laboratories Limited. It includes storage instructions at 20°-25°C (68°-77°F), a caution that it may cause dizziness, and a warning to keep drugs out of reach of children. The package contains 90 capsules and shows a barcode and lot number 1523487.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.